ENTRY       D11014            Mixture   Drug
NAME        Glecaprevir and pibrentasvir;
            Mavyret (TN)
PRODUCT     MAVYRET (AbbVie)
COMPONENT   (Glecaprevir [DR:D10814] | Glecaprevir hydrate [DR:D10815]), Pibrentasvir [DR:D10816]
CLASS       Antiviral
             DG03198  Anti-HCV agent
            Transporter substrate
             DG01665  ABCB1 substrate
             DG01913  ABCG2 substrate
             DG02856  SLCO1B1 substrate
             DG02932  SLCO1B3 substrate
            Transporter inhibitor
             DG01622  ABCB1 inhibitor
             DG02862  ABCG2 inhibitor
             DG02865  SLCO1B1 inhibitor
             DG02907  SLCO1B3 inhibitor
REMARK      Therapeutic category: 6250
            ATC code: J05AP57
            Product: D11014<JP/US>
EFFICACY    Antiviral
  DISEASE   Chronic hepatitis C virus infection [DS:H00413]
COMMENT     Glecaprevir is an inhibitor and a substrate of P-gp, BCRP, OATP1B1/1B3.
            Pibrentasvir is a substrate of P-gp; it is also an inhibitor of P-gp, BCRP and OATP1B1.
TARGET      HCV NS3/4A protease [KO:K22273 K22274]
            HCV NS5A [KO:K22275]
METABOLISM  Transporter: ABCB1 [HSA:5243], ABCG2 [HSA:9429], SLCO1B1 [HSA:10599], SLCO1B3 [HSA:28234]
INTERACTION Transporter inhibition: ABCB1 [HSA:5243], ABCG2 [HSA:9429], SLCO1B1 [HSA:10599], SLCO1B3 [HSA:28234]
BRITE       Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
             J ANTIINFECTIVES FOR SYSTEMIC USE
              J05 ANTIVIRALS FOR SYSTEMIC USE
               J05A DIRECT ACTING ANTIVIRALS
                J05AP Antivirals for treatment of HCV infections
                 J05AP57 Glecaprevir and pibrentasvir
                  D11014  Glecaprevir and pibrentasvir &lt;JP/US&gt;
            USP drug classification [BR:br08302]
             Antivirals
              Anti-hepatitis C (HCV) Agents
               Glecaprevir/ Pibrentasvir
                D11014  Glecaprevir and pibrentasvir
            Therapeutic category of drugs in Japan [BR:br08301]
             6  Agents against pathologic organisms and parasites
              62  Chemotherapeutics
               625  Antivirals
                6250  Antivirals
                 D11014  Glecaprevir and pibrentasvir
            Drug groups [BR:br08330]
             Antiviral
              DG03198  Anti-HCV agent
               D11014  Glecaprevir and pibrentasvir
             Transporter substrate
              DG01665  ABCB1 substrate
               D11014  Glecaprevir and pibrentasvir
              DG01913  ABCG2 substrate
               D11014  Glecaprevir and pibrentasvir
              DG02856  SLCO1B1 substrate
               D11014  Glecaprevir and pibrentasvir
              DG02932  SLCO1B3 substrate
               D11014  Glecaprevir and pibrentasvir
             Transporter inhibitor
              DG01622  ABCB1 inhibitor
               D11014  Glecaprevir and pibrentasvir
              DG02862  ABCG2 inhibitor
               D11014  Glecaprevir and pibrentasvir
              DG02865  SLCO1B1 inhibitor
               D11014  Glecaprevir and pibrentasvir
              DG02907  SLCO1B3 inhibitor
               D11014  Glecaprevir and pibrentasvir
            Drug classes [BR:br08332]
             Antiviral
              DG03198  Anti-HCV agent
               D11014  Glecaprevir and pibrentasvir
            Antimicrobials [BR:br08307]
             Antivirals
              Polyprotein cleavage inhibitor
               HCV NS3/4A inhibitor
                D11014  Glecaprevir and pibrentasvir &lt;JP/US&gt;
            New drug approvals in the USA [br08319.html]
             New molecular entities and new therapeutic biological products
              D11014
            New drug approvals in Europe [br08329.html]
             European public assessment reports (EPAR) authorised medicine
              D11014
            New drug approvals in Japan [br08318.html]
             Drugs with new active ingredients
              D11014
            New drug approvals in the USA, Europe and Japan [br08328.html]
             Approval dates by FDA, EMA and PMDA
              D11014
            Drug metabolizing enzymes and transporters [br08309.html]
             Drug transporters
              D11014
DBLINKS     PubChem: 348350486
///
